The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

BULK, Saskia; Berkhof, J.; Rozendaal, L.; Fransen Daalmeijer, N. C.; Gok, M.; de Schipper, F. A.; van Kemenade, F. J.; Snijders, P. J. F.; Meijer, C. J. L. M.

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

By Saskia BULK, J. Berkhof, L. Rozendaal, N. C. Fransen Daalmeijer, M. Gok, F. A. de Schipper, F. J. van Kemenade, P. J. F. Snijders and C. J. L. M. Meijer

Abstract

In one geographical area, 14 high-risk human papillomavirus types in cervical intraepithelial neoplasia (CIN2/3; n=139) and cervical squamous cell carcinoma (SCC; n=84) were analysed. HPV18 was more prevalent in SCC than CIN2/3 (OR 9.8; 95% confidence interval: 2.5-39). Other high-risk types prevalences corresponded in CIN2/3 and SCC. Evaluations using CIN2/3 as a measure of efficiency underestimate the contribution of HPV18 to SCC.Peer reviewe

Topics: Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell/virology, Cervical Intraepithelial Neoplasia/virology, Cross-Sectional Studies, Female, Human papillomavirus 18/isolation & purification, Humans, Middle Aged, Uterine Cervical Neoplasms/virology, Life sciences :: Genetics & genetic processes, Sciences du vivant :: Génétique & processus génétiques

Year: 2007

OAI identifier: oai:orbi.ulg.ac.be:2268/181846

Provided by: Open Repository and Bibliography

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://orbi.uliege.be/handle/... (external link)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

Abstract

Suggested articles